Skip to main content
PMC home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2010 Mar 2;6(1):50–55. doi: 10.1007/s13181-010-0038-1

Melamine Toxicity

Carl G Skinner 1,✉, Jerry D Thomas 2, John D Osterloh 2
PMCID: PMC3550444  PMID: 20195812

Abstract

Melamine contamination of infant formula in China and its health effects highlight the safety of the global food supply especially as it relates to formula-fed infants. Melamine is a widely used industrial chemical not considered acutely toxic with a high LD50 in animals. The data available on acute and chronic human exposure to melamine have been limited and extrapolated from animal data. Pet food contamination in 2004 and 2007 showed stone formation and illness in animals when melamine was co-ingested with cyanuric acid. The recent outbreak in infants showed that melamine ingested in large doses may cause stones and illness without significant ingestion of cyanuric acid or other melamine-related chemicals. This may be due to increased uric acid excretion in infants and formation of melamine–uric acid stones. Diagnosis and treatment of infants exposed to melamine requires further study. Clinical signs and symptoms in infants are nonspecific. The stones may be radiolucent and are not consistently seen on ultrasound. The use of alkalinization of the urine for treatment has been proposed, but is of unproven benefit. The FDA and other regulatory agencies have recommended acceptable levels of melamine in foods for consumption. Melamine ingestion has been implicated in stone formation when co-ingested with cyanuric acid, but will cause urinary stones in infants when large amounts of melamine alone are ingested.

Keywords: Melamine, Cyanuric acid, Infant formula, Nephrolithiasis, Kidney failure

Full Text

The Full Text of this article is available as a PDF (143.6 KB).

References

  • 1.Brown CA, Jeong KS, Poppenga RH, Puschner B, Miller DM, Ellis AE, et al. Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J Vet Diagn Invest. 2007;19(5):525–531. doi: 10.1177/104063870701900510. [DOI] [PubMed] [Google Scholar]
  • 2.US Food and Drug Administration (2008) Pet food recall (melamine)/tainted animal feed. US Food and Drug Administration, Rockville, MD. http://www.fda.gov/oc/opacom/hottopics/petfood.html, accessed February 25, 2009
  • 3.US Food and Drug Administration (2007) FDA’s ongoing pet food investigation. US Food and Drug Administration, Rockville, MD, April 16, 2007. http://www.fda.gov/consumer/updates/petfoodrecallup.html, accessed February 25, 2009
  • 4.Mast RW, Jeffcoat AR, Sadler BM, Kraska RC, Friedman MA. Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats. Food Chem Toxicol. 1983;21(6):807–810. doi: 10.1016/0278-6915(83)90216-8. [DOI] [PubMed] [Google Scholar]
  • 5.Melnick RL, Boorman GA, Haseman JK, Montali RJ, Huff J. Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol. 1984;72(2):292–303. doi: 10.1016/0041-008X(84)90314-4. [DOI] [PubMed] [Google Scholar]
  • 6.IUCLID dataset substance ID: 108-78-1. Melamine. In. 18 Feb ed: European Commission, European Chemicals Bureau; 2000
  • 7.National Toxicology Program NTP carcinogenesis bioassay of melamine (CAS No. 108-78-1) in F344/N rats and B6C3F1 Mice (Feed Study) Natl Toxicol Program Tech Rep Ser. 1983;245:1–171. [PubMed] [Google Scholar]
  • 8.Ogasawara H, Imaida K, Ishiwata H, Toyoda K, Kawanishi T, Uneyama C, et al. Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolith formation. Carcinogenesis. 1995;16(11):2773–2777. doi: 10.1093/carcin/16.11.2773. [DOI] [PubMed] [Google Scholar]
  • 9.Okumura M, Hasegawa R, Shirai T, Ito M, Yamada S, Fukushima S. Relationship between calculus formation and carcinogenesis in the urinary bladder of rats administered the non-genotoxic agents thymine or melamine. Carcinogenesis. 1992;13(6):1043–1045. doi: 10.1093/carcin/13.6.1043. [DOI] [PubMed] [Google Scholar]
  • 10.Reimschuessel R, Gieseker CM, Miller RA, Ward J, Boehmer J, Rummel N, et al. Evaluation of the renal effects of experimental feeding of melamine and cyanuric acid to fish and pigs. Am J Vet Res. 2008;69(9):1217–1228. doi: 10.2460/ajvr.69.9.1217. [DOI] [PubMed] [Google Scholar]
  • 11.Puschner B, Poppenga RH, Lowenstine LJ, Filigenzi MS, Pesavento PA. Assessment of melamine and cyanuric acid toxicity in cats. J Vet Diagn Invest. 2007;19(6):616–624. doi: 10.1177/104063870701900602. [DOI] [PubMed] [Google Scholar]
  • 12.US Food and Drug Administration (2009) Melamine contamination in China. US Food and Drug Administration, Rockville, MD, April 5, 2009. http://www.fda.gov/oc/opacom/hottopics/melamine.html, accessed February 25, 2009
  • 13.World Health Organization (2008) Melamine-contamination event. World Health Organization, Geneva, Switzerland, December 8, 2008. http://www.who.int/foodsafety/fs_management/infosan_events/en/index.html, accessed February 25, 2009
  • 14.World Health Organization (2008) Expert meeting to review toxicological aspects of melamine and cyanuric acid, in collaboration with FAO, supported by Health Canada, Ottawa, Canada, 1–4 December 2008, overall conclusions and recommendations. World Health Organization, Geneva, Switzerland. http://www.who.int/foodsafety/fs_management/conclusions_recommendations.pdf, accessed February 25, 2009
  • 15.Workshop on Melamine, 2008 November 18–19. Beijing, People’s Republic of China
  • 16.Bradley EL, Boughtflower V, Smith TL, Speck DR, Castle L. Survey of the migration of melamine and formaldehyde from melamine food contact articles available on the UK market. Food Addit Contam. 2005;22(6):597–606. doi: 10.1080/02652030500135243. [DOI] [PubMed] [Google Scholar]
  • 17.Ishiwata H, Inoue T, Tanimura A. Migration of melamine and formaldehyde from tableware made of melamine resin. Food Addit Contam. 1986;3(1):63–69. doi: 10.1080/02652038609373566. [DOI] [PubMed] [Google Scholar]
  • 18.Ishiwata H, Inoue T, Yamazaki T, Yoshihira K. Liquid chromatographic determination of melamine in beverages. J Assoc Off Anal Chem. 1987;70(3):457–460. [PubMed] [Google Scholar]
  • 19.Melamine GDCh-advisory Committee on Existing Chemicals of Environmental Relevance. BUA Report 1992 June, Germany, 105:1–27
  • 20.Dufour AP, Evans O, Behymer TD, Cantu R. Water ingestion during swimming activities in a pool: a pilot study. J Water Health. 2006;4(4):425–430. [PubMed] [Google Scholar]
  • 21.Allen LM, Briggle TV, Pfaffenberger CD. Absorption and excretion of cyanuric acid in long-distance swimmers. Drug Metab Rev. 1982;13(3):499–516. doi: 10.3109/03602538209029992. [DOI] [PubMed] [Google Scholar]
  • 22.Ranganathan A, Pedireddi VR, Rao CNR. Hydrothermal synthesis of organic channel structures: 1:1 hydrogen-bonded adducts of melamine with cyanuric and trithiocyanuric acids. J Am Chem Soc. 1999;121(8):1752–1753. doi: 10.1021/ja983928o. [DOI] [Google Scholar]
  • 23.Archer EA, Gong H, Krische MJ. Hydrogen bonding in noncovalent synthesis: selectivity and the directed organization of molecular strands. Tetrahedron. 2001;57(7):1139–1159. doi: 10.1016/S0040-4020(00)00986-8. [DOI] [Google Scholar]
  • 24.Perdigao LM, Champness NR, Beton PH. Surface self-assembly of the cyanuric acid–melamine hydrogen bonded network. Chem Commun (Camb) 2006;5:538–540. doi: 10.1039/b514389f. [DOI] [PubMed] [Google Scholar]
  • 25.Whitesides GM, Mathias JP, Seto CT. Molecular self-assembly and nanochemistry: a chemical strategy for the synthesis of nanostructures. Science. 1991;254(5036):1312–1319. doi: 10.1126/science.1962191. [DOI] [PubMed] [Google Scholar]
  • 26.Whitesides GM, Simanek EE, Mathias JP, Seto CT, Chin D, Mammen M, et al. Noncovalent synthesis: using physical-organic chemistry to make aggregates. Acc Chem Res. 1995;28(1):37–44. doi: 10.1021/ar00049a006. [DOI] [Google Scholar]
  • 27.US Food and Drug Administration (2007) Interim melamine and analogues safety/risk assessment. US Food and Drug Administration, Rockville, MD, May 25, 2007. http://www.cfsan.fda.gov/∼dms/melamra.html, accessed February 25, 2009
  • 28.Baynes RE, Smith G, Mason SE, Barrett E, Barlow BM, Riviere JE. Pharmacokinetics of melamine in pigs following intravenous administration. Food Chem Toxicol. 2008;46(3):1196–1200. doi: 10.1016/j.fct.2007.11.013. [DOI] [PubMed] [Google Scholar]
  • 29.Cremonezzi DC, Diaz MP, Valentich MA, Eynard AR. Neoplastic and preneoplastic lesions induced by melamine in rat urothelium are modulated by dietary polyunsaturated fatty acids. Food Chem Toxicol. 2004;42(12):1999–2007. doi: 10.1016/j.fct.2004.06.020. [DOI] [PubMed] [Google Scholar]
  • 30.Heck HD, Tyl RW. The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-s-triazine) and its relevance to risk assessment. Regul Toxicol Pharmacol. 1985;5(3):294–313. doi: 10.1016/0273-2300(85)90044-3. [DOI] [PubMed] [Google Scholar]
  • 31.Clark R. Melamine crystalluria in sheep. Journal South African Veterinary Medical Assoc. 1966;37:349–351. [Google Scholar]
  • 32.Thiersch JB. Effect of 2,4,6-triamino-“s”-triazine (TR), 2,4,6-“tris”(ethyleneamino)-“s”-triazine (TEM) and N,N′,N″-triethyl-enephosphoramide (TEPA) on rat litter in utero. Proc Soc Exp Biol Med. 1957;94:36–40. doi: 10.3181/00379727-94-22849. [DOI] [PubMed] [Google Scholar]
  • 33.Dobson RL, Motlagh S, Quijano M, Cambron RT, Baker TR, Pullen AM, et al. Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. Toxicol Sci. 2008;106(1):251–262. doi: 10.1093/toxsci/kfn160. [DOI] [PubMed] [Google Scholar]
  • 34.Cianciolo RE, Bischoff K, Ebel JG, Van Winkle TJ, Goldstein RE, Serfilippi LM. Clinicopathologic, histologic, and toxicologic findings in 70 cats inadvertently exposed to pet food contaminated with melamine and cyanuric acid. J Am Vet Med Assoc. 2008;233(5):729–737. doi: 10.2460/javma.233.5.729. [DOI] [PubMed] [Google Scholar]
  • 35.Hong Kong Centre for Food Safety (2008) Frequently asked questions. Hong Kong Centre for Food Safety, Hong Kong, December 24, 2008. http://www.cfs.gov.hk/english/whatsnew/whatsnew_fstr/whatsnew_fstr_Test_dairy_product_FAQ.html, accessed February 25, 2009
  • 36.Lam CW, Lan L, Che X, Tam S, Wong SS, Chen Y, et al. Diagnosis and spectrum of melamine-related renal disease: plausible mechanism of stone formation in humans. Clin Chim Acta. 2009;402(1–2):150–155. doi: 10.1016/j.cca.2008.12.035. [DOI] [PubMed] [Google Scholar]
  • 37.Guan N, Fan Q, Ding J, Zhao Y, Lu J, Ai Y, et al. Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med. 2009;360(11):1067–1074. doi: 10.1056/NEJMoa0809550. [DOI] [PubMed] [Google Scholar]
  • 38.Stapleton FB, Linshaw MA, Hassanein K, Gruskin AB. Uric acid excretion in normal children. J Pediatr. 1978;92(6):911–914. doi: 10.1016/S0022-3476(78)80359-X. [DOI] [PubMed] [Google Scholar]
  • 39.Stapleton FB. Renal uric acid clearance in human neonates. J Pediatr. 1983;103(2):290–294. doi: 10.1016/S0022-3476(83)80369-2. [DOI] [PubMed] [Google Scholar]
  • 40.Matos V, Van Melle G, Werner D, et al. Urinary oxalate and urate to creatinine ratios in a healthy pediatric population. Am J Kidney Dis. 1999;34(2):e1. doi: 10.1053/AJKD034000e6. [DOI] [PubMed] [Google Scholar]
  • 41.Lam HS, Ng PC, Chu WC, Wong W, Chan DF, Ho SS, et al. Renal screening in children after exposure to low dose melamine in Hong Kong: cross sectional study. BMJ. 2008;337:a2991. doi: 10.1136/bmj.a2991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.US Food and Drug Administration (2008) Update interim safety and risk assessment of melamine and its analogues in food for humans. US Food and Drug Administration, Rockville, MD, November 28, 2008. http://www.cfsan.fda.gov/∼dms/melamra4.html, accessed February 25, 2009
  • 43.Health Canada (2008) Canada becomes first country to adopt new World Health Organization recommendations regarding melamine in food. Health Canada, Ottawa, Canada, December 10, 2008. http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2008/2008_181-eng.php, accessed February 26, 2009
  • 44.European Food Safety Authority (2008) Statement of EFSA on risks for public health due to the presences of melamine in infant milk and other milk products in China. European Food Safety Authority, Parma, Italy, September 24, 2008. http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902098495.htm, accessed February 26, 2009
  • 45.Hsieh DP, Chiang CF, Chiang PH, Wen CP. Toxicological analysis points to a lower tolerable daily intake of melamine in food. Regul Toxicol Pharmacol. 2009;55:13–16. doi: 10.1016/j.yrtph.2009.05.004. [DOI] [PubMed] [Google Scholar]
  • 46.Nicoletta JA, Lande MB. Medical evaluation and treatment of urolithiasis. Pediatr Clin North Am. 2006;53(3):479–491. doi: 10.1016/j.pcl.2006.03.001. [DOI] [PubMed] [Google Scholar]
  • 47.Dogan HS, Tekgul S. Management of pediatric stone disease. Curr Urol Rep. 2007;8(2):163–173. doi: 10.1007/s11934-007-0067-8. [DOI] [PubMed] [Google Scholar]
  • 48.Pak CY. Pharmacotherapy of kidney stones. Expert Opin Pharmacother. 2008;9(9):1509–1518. doi: 10.1517/14656566.9.9.1509. [DOI] [PubMed] [Google Scholar]
  • 49.Wang IJ, Chen PC, Hwang KC. Melamine and nephrolithiasis in children in Taiwan. N Engl J Med. 2009;360(11):1157–1158. doi: 10.1056/NEJMc0810070. [DOI] [PubMed] [Google Scholar]
  • 50.Ho SS, Chu WC, Wong KT, Li CK, Wong W, Ng PC, et al. Ultrasonographic evaluation of melamine-exposed children in Hong Kong. N Engl J Med. 2009;360(11):1156–1157. doi: 10.1056/NEJMc0809955. [DOI] [PubMed] [Google Scholar]
  • 51.Mandeville JA, Nelson CP. Pediatric urolithiasis. Curr Opin Urol. 2009;19(4):419–423. doi: 10.1097/MOU.0b013e32832c9096. [DOI] [PubMed] [Google Scholar]
  • 52.Zhu SL, Li JH, Chen L, et al. Conservative management of pediatric nephrolithiasis caused by melamine-contaminated milk powder. Pediatrics. 2009;123(6):e1099–e1102. doi: 10.1542/peds.2008-3659. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES